Hannah Shilling

438 total citations · 1 hit paper
14 papers, 266 citations indexed

About

Hannah Shilling is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Hannah Shilling has authored 14 papers receiving a total of 266 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Epidemiology, 5 papers in Microbiology and 3 papers in Infectious Diseases. Recurrent topics in Hannah Shilling's work include Cervical Cancer and HPV Research (6 papers), Reproductive tract infections research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Hannah Shilling is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), Reproductive tract infections research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Hannah Shilling collaborates with scholars based in Australia, Denmark and Malaysia. Hannah Shilling's co-authors include Dorothy A. Machalek, Christopher K. Fairley, Catriona S. Bradshaw, Eric P. F. Chow, Lenka A. Vodstrcil, Suzanne M. Garland, Gerald L. Murray, Jane S. Hocking, Magnus Unemo and Jørgen Skov Jensen and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and The Lancet Infectious Diseases.

In The Last Decade

Hannah Shilling

13 papers receiving 262 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis

2020 174 citations Dorothy A. Machalek, Yusha Tao et al. The Lancet Infectious Diseases profile →

Peers

Hannah Shilling

MICRO

EPIDE

HEMAT

SURGE

PHYSI

Kirsten Salado-Rasmussen Denmark

Kohsuke Mizutani Japan

Rachel Pitt United Kingdom

E Lanjouw Netherlands

Irene Santo Portugal

J Nasio Canada

Patrick Descheemaeker Belgium

Nobuko Maki Japan

Natalie Banniettis United States

Richard E. Kaufman United States

Kirsten Salado-Rasmussen Denmark

Hannah Shilling

257 ×1.3

MICRO

76 ×0.8

EPIDE

96 ×1.0

HEMAT

90 ×1.2

SURGE

144 ×2.4

PHYSI

Citations per year, relative to Hannah Shilling Hannah Shilling (= 1×) peers Kirsten Salado-Rasmussen

Countries citing papers authored by Hannah Shilling

Since Specialization

Citations

This map shows the geographic impact of Hannah Shilling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hannah Shilling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hannah Shilling more than expected).

Fields of papers citing papers by Hannah Shilling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hannah Shilling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hannah Shilling. The network helps show where Hannah Shilling may publish in the future.

Co-authorship network of co-authors of Hannah Shilling

This figure shows the co-authorship network connecting the top 25 collaborators of Hannah Shilling. A scholar is included among the top collaborators of Hannah Shilling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hannah Shilling. Hannah Shilling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Shilling, Hannah, Gerald L. Murray, Mónica Molano, et al.. (2024). Human Papillomavirus Prevalence Among Australian Men Aged 18–35 Years in 2015–2018 According to Vaccination Status and Sexual Orientation. The Journal of Infectious Diseases. 231(2). 451–461. 4 indexed citations

Baum, Sandra, et al.. (2024). Who and what supports systemic working in a learning disabilities context?. Clinical Psychology Forum. 1(372). 60–67.

Brotherton, Julia, Megan A. Smith, Dorothy A. Machalek, et al.. (2023). Implementation of Australia’s primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study. Preventive Medicine Reports. 33. 102213–102213. 3 indexed citations

Machalek, Dorothy A., John B. Carlin, Suellen Nicholson, et al.. (2022). Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020. PLoS ONE. 17(7). e0265858–e0265858. 2 indexed citations

Shilling, Hannah, Suzanne M. Garland, Anna‐Maria Costa, et al.. (2021). Chlamydia trachomatisandMycoplasma genitaliumprevalence and associated factors among women presenting to a pregnancy termination and contraception clinic, 2009–2019. Sexually Transmitted Infections. 98(2). 115–120. 7 indexed citations

Shilling, Hannah, Suzanne M. Garland, Alyssa M. Cornall, et al.. (2021). Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction. Vaccine. 39(34). 4856–4863. 10 indexed citations

Gidding, Heather F., Dorothy A. Machalek, Alexandra Hendry, et al.. (2021). Seroprevalence of SARS‐CoV‐2‐specific antibodies in Sydney after the first epidemic wave of 2020. The Medical Journal of Australia. 214(4). 179–185. 19 indexed citations

Shilling, Hannah, Dorothy A. Machalek, David Hawkes, et al.. (2021). Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay. Journal of Applied Microbiology. 131(5). 2592–2599. 7 indexed citations

Gidding, Heather F., Dorothy A. Machalek, Alexandra Hendry, et al.. (2020). Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020. The Medical Journal of Australia. 1. 5 indexed citations

10.

Machalek, Dorothy A., Yusha Tao, Hannah Shilling, et al.. (2020). Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis. The Lancet Infectious Diseases. 20(11). 1302–1314. 174 indexed citations breakdown →

11.

Shilling, Hannah, Lenka A. Vodstrcil, Dorothy A. Machalek, et al.. (2020). Prevalence ofMycoplasma genitaliumby anatomical site in men who have sex with men: a systematic review and meta-analysis. Sexually Transmitted Infections. 96(8). 563–570. 25 indexed citations

12.

Machalek, Dorothy A., Yusha Tao, Hannah Shilling, et al.. (2019). P601 Macrolide and fluoroquinolone resistance-associated mutations inmycoplasma genitalium:a systematic review and meta-analysis. Poster presentations. A266.2–A266. 1 indexed citations

13.

Machalek, Dorothy A., Hannah Shilling, Alyssa M. Cornall, et al.. (2019). P822 Factors associated with oncogenic human papillomavirus prevalence among australian women following vaccine introduction. Poster presentations. A345.3–A346. 1 indexed citations

14.

Shilling, Hannah, Gerald L. Murray, Julia Brotherton, et al.. (2019). Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening. Vaccine. 38(5). 1186–1193. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact